©The Author(s) 2025.
World J Clin Oncol. Dec 24, 2025; 16(12): 112443
Published online Dec 24, 2025. doi: 10.5306/wjco.v16.i12.112443
Published online Dec 24, 2025. doi: 10.5306/wjco.v16.i12.112443
Table 3 Multivariable Cox regression by primary tumor site
| Primary tumor site | HR | 95%CI | P value |
| Breast cancer (reference) | 1.00 | - | - |
| Small bowel | 25.21 | 3.53-180.14 | < 0.005 |
| Biliary tract | 32.53 | 4.22-250.70 | < 0.005 |
| Pancreas | 24.34 | 1.62-365.44 | 0.021 |
| Uterus | 6.71 | 1.72-26.11 | 0.006 |
| Sarcoma | 2.38 | 0.46-12.34 | 0.30 |
| MPM | 1.33 | 0.30-5.83 | 0.70 |
| Miscellaneous | 1.05 | 0.32-3.38 | 0.94 |
- Citation: Framarini M, D'Acapito F, Lippolis PV, Di Giorgio A, Di Pietrantonio D, Sommariva A, Sammartino P. Expanding the role of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A multicenter study on uncommon peritoneal malignancies. World J Clin Oncol 2025; 16(12): 112443
- URL: https://www.wjgnet.com/2218-4333/full/v16/i12/112443.htm
- DOI: https://dx.doi.org/10.5306/wjco.v16.i12.112443